Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Daniel Pollyea

Concepts (466)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
112
2025
622
25.780
 Why?
Bridged Bicyclo Compounds, Heterocyclic
38
2025
227
10.480
 Why?
Sulfonamides
33
2025
512
8.510
 Why?
Antineoplastic Combined Chemotherapy Protocols
49
2025
1688
7.790
 Why?
Azacitidine
23
2024
141
6.500
 Why?
Myelodysplastic Syndromes
28
2023
135
6.320
 Why?
Antineoplastic Agents
25
2025
2135
3.170
 Why?
Mutation
36
2025
3956
3.160
 Why?
Isocitrate Dehydrogenase
13
2022
60
2.960
 Why?
Hematologic Neoplasms
10
2023
155
2.780
 Why?
Neoplastic Stem Cells
14
2025
400
2.360
 Why?
Hematopoietic Stem Cell Transplantation
17
2024
615
2.290
 Why?
Neoplasm, Residual
7
2024
133
2.280
 Why?
Triazines
7
2021
43
1.950
 Why?
Aminopyridines
7
2021
99
1.890
 Why?
Graft vs Host Disease
9
2024
249
1.700
 Why?
Remission Induction
15
2021
288
1.520
 Why?
Prognosis
28
2025
4026
1.520
 Why?
RNA Splicing Factors
3
2020
53
1.440
 Why?
Humans
156
2025
137294
1.340
 Why?
Aged, 80 and over
33
2025
7607
1.320
 Why?
Aged
59
2025
23851
1.290
 Why?
Phosphoproteins
3
2020
338
1.240
 Why?
Cytarabine
8
2022
61
1.230
 Why?
Leukemia
4
2023
238
1.120
 Why?
Neoplasm Recurrence, Local
5
2020
1058
1.120
 Why?
Treatment Outcome
34
2025
10800
1.120
 Why?
Salvage Therapy
5
2023
142
1.010
 Why?
Clonal Evolution
2
2017
45
0.980
 Why?
Cord Blood Stem Cell Transplantation
4
2024
99
0.970
 Why?
Drug Resistance, Neoplasm
9
2025
802
0.890
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
73
0.890
 Why?
fms-Like Tyrosine Kinase 3
4
2017
47
0.890
 Why?
Nuclear Proteins
5
2018
712
0.870
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
288
0.870
 Why?
Middle Aged
47
2025
33310
0.850
 Why?
Molecular Targeted Therapy
7
2024
413
0.840
 Why?
Transplantation Conditioning
9
2024
170
0.820
 Why?
Carrier Proteins
3
2017
769
0.810
 Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.810
 Why?
Spliceosomes
2
2020
48
0.770
 Why?
Dancing
1
2022
16
0.770
 Why?
Thrombocytopenia
2
2023
199
0.770
 Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
234
0.740
 Why?
Anemia
2
2020
170
0.730
 Why?
Enzyme Inhibitors
5
2020
839
0.730
 Why?
Febrile Neutropenia
1
2020
6
0.700
 Why?
Male
56
2025
67560
0.680
 Why?
Splicing Factor U2AF
2
2023
16
0.670
 Why?
Female
61
2025
73052
0.660
 Why?
Receptors, Colony-Stimulating Factor
2
2017
7
0.650
 Why?
Serine-Arginine Splicing Factors
2
2019
22
0.650
 Why?
Adult
34
2025
37724
0.640
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
121
0.630
 Why?
Phenylurea Compounds
7
2020
96
0.590
 Why?
DNA Methylation
3
2019
644
0.590
 Why?
Staurosporine
1
2017
20
0.570
 Why?
Stem Cells
3
2020
593
0.560
 Why?
Benzimidazoles
6
2020
168
0.540
 Why?
Protein Kinase Inhibitors
10
2025
916
0.510
 Why?
Gene Frequency
2
2017
521
0.510
 Why?
Recurrence
9
2023
1059
0.500
 Why?
Monocytes
2
2018
563
0.490
 Why?
Neoplasms, Plasma Cell
1
2015
6
0.490
 Why?
Glycine
4
2021
175
0.490
 Why?
Leukocytosis
1
2015
31
0.490
 Why?
Gene Expression
1
2020
1501
0.480
 Why?
Skin Neoplasms
1
2023
852
0.480
 Why?
High-Throughput Nucleotide Sequencing
2
2018
537
0.470
 Why?
Signal Transduction
9
2022
5078
0.470
 Why?
Retrospective Studies
16
2024
15639
0.450
 Why?
Epigenesis, Genetic
1
2019
659
0.450
 Why?
Precision Medicine
1
2018
428
0.450
 Why?
Maximum Tolerated Dose
5
2019
198
0.450
 Why?
Oxidative Phosphorylation
6
2024
193
0.440
 Why?
Pyridines
5
2023
506
0.440
 Why?
Patient Safety
1
2018
309
0.440
 Why?
Computational Biology
1
2019
646
0.440
 Why?
Medical Oncology
4
2023
291
0.440
 Why?
Induction Chemotherapy
3
2024
74
0.430
 Why?
Clinical Trials, Phase I as Topic
2
2024
51
0.430
 Why?
Clinical Trials, Phase III as Topic
2
2024
105
0.420
 Why?
Hematopoiesis
4
2020
190
0.420
 Why?
Neoplasm Proteins
4
2022
434
0.420
 Why?
Pyrazoles
1
2017
423
0.410
 Why?
Apoptosis
4
2018
2554
0.410
 Why?
Immunity, Innate
1
2019
827
0.400
 Why?
Germ-Line Mutation
3
2022
172
0.400
 Why?
Dose-Response Relationship, Drug
7
2021
2052
0.400
 Why?
Leukemia, Myeloid
1
2012
45
0.400
 Why?
Glutarates
1
2012
10
0.390
 Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
31
0.380
 Why?
RNA Splicing
4
2023
268
0.360
 Why?
Neutrophils
2
2023
1236
0.360
 Why?
Follow-Up Studies
8
2020
5125
0.350
 Why?
Drug Delivery Systems
1
2014
362
0.350
 Why?
Antibodies, Monoclonal, Humanized
7
2023
805
0.350
 Why?
United States Food and Drug Administration
2
2022
208
0.350
 Why?
Young Adult
15
2024
13163
0.340
 Why?
Aldehyde Dehydrogenase
3
2017
100
0.340
 Why?
Neoplasms
4
2018
2661
0.340
 Why?
Rhipicephalus sanguineus
1
2009
1
0.330
 Why?
Leukocyte Count
2
2024
331
0.330
 Why?
Triatoma
1
2009
7
0.330
 Why?
Wasps
1
2009
8
0.330
 Why?
Survival Rate
10
2020
1970
0.330
 Why?
Insect Bites and Stings
1
2009
12
0.330
 Why?
Syncope
1
2009
52
0.320
 Why?
Electron Transport Complex II
2
2019
26
0.310
 Why?
Cytokines
4
2020
2090
0.300
 Why?
Kaplan-Meier Estimate
5
2020
892
0.300
 Why?
Mutant Proteins
2
2019
101
0.300
 Why?
Influenza A Virus, H1N1 Subtype
1
2010
152
0.300
 Why?
Cell Self Renewal
2
2019
55
0.300
 Why?
Proto-Oncogene Proteins
2
2018
647
0.300
 Why?
Administration, Oral
4
2018
812
0.290
 Why?
Risk Assessment
5
2024
3439
0.290
 Why?
Acute Disease
3
2023
1009
0.290
 Why?
Anaphylaxis
1
2009
105
0.290
 Why?
Bone Marrow
4
2017
286
0.290
 Why?
Randomized Controlled Trials as Topic
3
2024
1464
0.290
 Why?
Transplantation, Homologous
6
2022
415
0.280
 Why?
Survival Analysis
6
2020
1321
0.280
 Why?
Gene Expression Regulation, Leukemic
3
2016
54
0.280
 Why?
Immunotherapy, Adoptive
2
2022
324
0.280
 Why?
Drug Administration Schedule
4
2020
786
0.270
 Why?
Disease-Free Survival
5
2022
687
0.270
 Why?
Thrombocythemia, Essential
2
2016
7
0.250
 Why?
Polycythemia Vera
2
2016
12
0.250
 Why?
Mitochondria
3
2024
947
0.250
 Why?
Primary Myelofibrosis
2
2016
10
0.250
 Why?
Animals
26
2025
36862
0.240
 Why?
Clinical Trials as Topic
4
2020
1045
0.240
 Why?
Cytogenetic Analysis
2
2022
33
0.240
 Why?
Hematopoietic Stem Cells
3
2022
402
0.240
 Why?
Phenotype
3
2025
3202
0.230
 Why?
Influenza Vaccines
1
2010
539
0.230
 Why?
DEAD-box RNA Helicases
2
2015
76
0.230
 Why?
Mice
18
2025
17774
0.230
 Why?
Biomarkers, Tumor
4
2019
1274
0.220
 Why?
Transplantation, Haploidentical
1
2024
22
0.220
 Why?
Allografts
2
2021
146
0.220
 Why?
Stem Cell Transplantation
3
2023
177
0.220
 Why?
Azetidines
1
2024
43
0.210
 Why?
Influenza, Human
1
2010
625
0.210
 Why?
Finland
1
2023
90
0.210
 Why?
DNA Mutational Analysis
4
2019
400
0.210
 Why?
Antibodies, Monoclonal
4
2017
1431
0.200
 Why?
DNA-Binding Proteins
1
2010
1501
0.200
 Why?
Drug Therapy, Combination
4
2022
1063
0.200
 Why?
Antibodies, Neoplasm
3
2007
34
0.200
 Why?
Disease Management
4
2021
627
0.200
 Why?
Uncertainty
1
2023
128
0.200
 Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.200
 Why?
RNA, Messenger
1
2010
2839
0.190
 Why?
Proto-Oncogene Proteins c-myc
2
2022
139
0.190
 Why?
Hematology
1
2022
20
0.190
 Why?
Lymphoma, Non-Hodgkin
1
2023
87
0.190
 Why?
Myeloproliferative Disorders
1
2022
27
0.190
 Why?
Piperidines
1
2024
206
0.190
 Why?
Thalidomide
2
2012
40
0.190
 Why?
Amino Acid Transport System ASC
1
2022
12
0.190
 Why?
Succinate Dehydrogenase
2
2019
50
0.190
 Why?
Minor Histocompatibility Antigens
1
2022
48
0.190
 Why?
Disease Progression
3
2023
2752
0.180
 Why?
Receptors, Mitogen
1
2021
9
0.180
 Why?
Polymerase Chain Reaction
1
2024
1061
0.180
 Why?
Lectins, C-Type
1
2021
67
0.180
 Why?
Blood Cell Count
1
2020
55
0.170
 Why?
Erythroblasts
1
2020
19
0.170
 Why?
Cell Transformation, Neoplastic
3
2018
327
0.170
 Why?
Lipase
1
2020
69
0.170
 Why?
Histocompatibility Testing
2
2019
126
0.170
 Why?
STAT3 Transcription Factor
1
2022
206
0.170
 Why?
Inflammation Mediators
2
2020
514
0.160
 Why?
Tumor Lysis Syndrome
1
2019
8
0.160
 Why?
Dendritic Cells
1
2023
484
0.160
 Why?
Chemical and Drug Induced Liver Injury
1
2021
136
0.160
 Why?
Immunoconjugates
1
2021
114
0.160
 Why?
Leukopoiesis
1
2019
11
0.160
 Why?
NADPH Oxidase 2
1
2019
39
0.160
 Why?
Myeloid Progenitor Cells
1
2019
17
0.160
 Why?
NF-kappa B p50 Subunit
1
2019
26
0.150
 Why?
Fatty Acids
2
2020
444
0.150
 Why?
K562 Cells
1
2019
89
0.150
 Why?
RAW 264.7 Cells
1
2019
50
0.150
 Why?
Tricarboxylic Acids
1
2018
10
0.150
 Why?
Ketoglutaric Acids
1
2018
16
0.150
 Why?
Age Factors
5
2022
3297
0.150
 Why?
Mycoses
1
2019
79
0.150
 Why?
Genetic Testing
2
2019
454
0.150
 Why?
Antibodies
1
2021
412
0.150
 Why?
Hematologic Diseases
1
2019
62
0.150
 Why?
Genomics
3
2019
792
0.150
 Why?
Tumor Suppressor Protein p53
1
2022
530
0.150
 Why?
United States
5
2023
14742
0.150
 Why?
Amino Acids
2
2020
501
0.150
 Why?
Antibiotic Prophylaxis
1
2019
117
0.150
 Why?
Mitochondrial Proteins
2
2018
256
0.150
 Why?
Thiotepa
1
2018
20
0.150
 Why?
Antimetabolites, Antineoplastic
1
2018
94
0.150
 Why?
Calcium
1
2024
1198
0.150
 Why?
Cell Line, Tumor
7
2025
3414
0.150
 Why?
Trees
1
2018
72
0.140
 Why?
Lymphoma
2
2017
208
0.140
 Why?
Cysteine
1
2019
205
0.140
 Why?
Fusion Proteins, bcr-abl
2
2014
69
0.140
 Why?
HLA-DR Antigens
1
2018
228
0.130
 Why?
Confidence Intervals
1
2018
330
0.130
 Why?
Mediastinal Neoplasms
1
2017
45
0.130
 Why?
Hematinics
1
2017
22
0.130
 Why?
Infusions, Intravenous
1
2018
412
0.130
 Why?
AMP-Activated Protein Kinases
1
2018
197
0.130
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
66
0.130
 Why?
Hedgehog Proteins
1
2018
197
0.130
 Why?
Periodicals as Topic
1
2019
211
0.130
 Why?
Unrelated Donors
1
2016
39
0.130
 Why?
Glucosephosphate Dehydrogenase
1
2016
60
0.130
 Why?
Cohort Studies
5
2022
5726
0.130
 Why?
Genome, Human
1
2018
425
0.120
 Why?
Pyrimidines
2
2017
471
0.120
 Why?
Nitriles
1
2017
172
0.120
 Why?
Geriatric Assessment
1
2018
224
0.120
 Why?
Energy Metabolism
2
2019
920
0.120
 Why?
Oncogene Proteins
1
2016
59
0.120
 Why?
NF-E2-Related Factor 2
1
2016
93
0.120
 Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
14
0.120
 Why?
Mice, Inbred NOD
4
2019
601
0.120
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
69
0.120
 Why?
Genetic Predisposition to Disease
2
2022
2419
0.120
 Why?
Methyltransferases
1
2016
78
0.120
 Why?
Lipopolysaccharides
1
2019
886
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2017
251
0.120
 Why?
Oligomycins
1
2014
7
0.120
 Why?
Electronic Health Records
1
2023
1045
0.120
 Why?
Biomarkers
3
2022
4164
0.120
 Why?
Hemoglobins
2
2018
353
0.120
 Why?
Chromosome Aberrations
1
2015
155
0.120
 Why?
Mitochondrial Proton-Translocating ATPases
1
2014
19
0.120
 Why?
Adolescent
7
2024
21499
0.110
 Why?
Homeostasis
1
2018
619
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2015
317
0.110
 Why?
Cell Survival
4
2022
1119
0.110
 Why?
Necrosis
1
2015
245
0.110
 Why?
T-Lymphocytes
1
2022
1998
0.110
 Why?
Calcineurin Inhibitors
1
2014
72
0.110
 Why?
Histone-Lysine N-Methyltransferase
1
2016
137
0.110
 Why?
Cells, Cultured
5
2019
4197
0.110
 Why?
Vidarabine
2
2018
33
0.110
 Why?
Harringtonines
1
2013
2
0.110
 Why?
Predictive Value of Tests
1
2019
2032
0.110
 Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.100
 Why?
Tumor Suppressor Proteins
1
2016
327
0.100
 Why?
Alemtuzumab
3
2007
15
0.100
 Why?
Glucose
1
2018
1028
0.100
 Why?
Registries
2
2023
2016
0.100
 Why?
Interleukin-1
1
2017
964
0.100
 Why?
Gene Expression Profiling
3
2019
1774
0.100
 Why?
Pyridazines
1
2013
56
0.100
 Why?
Carbon Monoxide
1
2013
80
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1399
0.100
 Why?
Nausea
1
2012
112
0.100
 Why?
5-Methylcytosine
1
2012
22
0.100
 Why?
Vomiting
1
2012
130
0.090
 Why?
Biopsy
1
2015
1127
0.090
 Why?
Imidazoles
1
2013
239
0.090
 Why?
Liver
1
2020
1941
0.090
 Why?
Membrane Proteins
1
2018
1163
0.090
 Why?
Core Binding Factor Alpha 2 Subunit
2
2023
31
0.090
 Why?
Incidence
2
2016
2808
0.090
 Why?
Amino Acid Sequence
2
2015
2147
0.090
 Why?
Dioxygenases
1
2010
28
0.090
 Why?
Sesquiterpenes
2
2016
55
0.090
 Why?
Fatigue
1
2012
328
0.080
 Why?
Length of Stay
1
2016
1218
0.080
 Why?
Oxidants
1
2011
111
0.080
 Why?
Software
1
2015
667
0.080
 Why?
GTP-Binding Proteins
1
2011
161
0.080
 Why?
Ethanol
1
2015
608
0.080
 Why?
Wasp Venoms
1
2009
4
0.080
 Why?
Chronic Disease
1
2016
1788
0.080
 Why?
Insulin Resistance
1
2018
1203
0.080
 Why?
Blast Crisis
2
2025
33
0.080
 Why?
Protein Multimerization
1
2011
193
0.080
 Why?
Injections, Subcutaneous
1
2009
154
0.080
 Why?
Hydrogen Peroxide
1
2011
328
0.080
 Why?
Epinephrine
1
2009
139
0.080
 Why?
Mice, Transgenic
3
2023
2164
0.080
 Why?
Adjuvants, Immunologic
1
2010
226
0.070
 Why?
Emergencies
1
2009
165
0.070
 Why?
Immunization Schedule
1
2010
197
0.070
 Why?
RNA, Small Interfering
3
2016
622
0.070
 Why?
Melphalan
1
2007
35
0.070
 Why?
Inflammation
1
2019
2836
0.070
 Why?
Blood Transfusion
2
2020
326
0.070
 Why?
Transplantation Chimera
1
2007
54
0.070
 Why?
Tumor Cells, Cultured
2
2022
954
0.070
 Why?
Karnofsky Performance Status
1
2006
38
0.070
 Why?
HEK293 Cells
2
2019
731
0.060
 Why?
Mice, Inbred C57BL
4
2020
5753
0.060
 Why?
Receptors, Thrombopoietin
2
2016
6
0.060
 Why?
Calreticulin
2
2016
27
0.060
 Why?
Protein-Tyrosine Kinases
3
2014
434
0.060
 Why?
Janus Kinase 2
2
2016
32
0.060
 Why?
Exome
2
2018
231
0.060
 Why?
Ganciclovir
1
2006
53
0.060
 Why?
Evidence-Based Medicine
1
2010
740
0.060
 Why?
Valine
1
2006
82
0.060
 Why?
Acyclovir
1
2006
101
0.060
 Why?
Philadelphia Chromosome
2
2016
18
0.060
 Why?
Risk Factors
3
2014
10368
0.060
 Why?
Cell Proliferation
3
2020
2479
0.060
 Why?
Bone Marrow Transplantation
1
2006
287
0.060
 Why?
Janus Kinases
2
2015
15
0.060
 Why?
Pedigree
2
2015
514
0.050
 Why?
Oxidation-Reduction
2
2019
1069
0.050
 Why?
Cytomegalovirus Infections
1
2006
191
0.050
 Why?
Diamines
1
2023
4
0.050
 Why?
Antigens, CD34
1
2023
88
0.050
 Why?
Chemotaxis
1
2023
130
0.050
 Why?
Xenograft Model Antitumor Assays
2
2016
870
0.050
 Why?
Breast Neoplasms
1
2015
2243
0.050
 Why?
Flow Cytometry
2
2018
1184
0.050
 Why?
Angiogenesis Inhibitors
1
2004
226
0.050
 Why?
Practice Guidelines as Topic
1
2010
1577
0.050
 Why?
Neutropenia
1
2022
146
0.050
 Why?
Drug Interactions
2
2013
406
0.050
 Why?
Early Termination of Clinical Trials
1
2021
17
0.040
 Why?
Quinuclidines
1
2020
10
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
75
0.040
 Why?
Hyperbilirubinemia
1
2020
13
0.040
 Why?
Receptors, Cell Surface
1
2022
386
0.040
 Why?
Niacinamide
1
2020
79
0.040
 Why?
Antiviral Agents
1
2006
741
0.040
 Why?
Proportional Hazards Models
2
2017
1260
0.040
 Why?
Neoplasms, Second Primary
1
2021
116
0.040
 Why?
Lentivirus
1
2019
56
0.040
 Why?
Multicenter Studies as Topic
1
2020
308
0.040
 Why?
Disease Susceptibility
1
2021
345
0.040
 Why?
Daunorubicin
1
2018
26
0.040
 Why?
Consolidation Chemotherapy
1
2018
10
0.040
 Why?
Mice, Nude
2
2015
696
0.040
 Why?
Maintenance Chemotherapy
1
2018
35
0.040
 Why?
Drug Monitoring
1
2020
219
0.040
 Why?
Myeloablative Agonists
1
2018
22
0.040
 Why?
Mice, SCID
1
2019
367
0.040
 Why?
Iron
1
2020
313
0.040
 Why?
Datasets as Topic
1
2018
119
0.040
 Why?
Mice, Knockout
2
2016
3009
0.040
 Why?
Forkhead Transcription Factors
1
2019
190
0.040
 Why?
Cause of Death
1
2020
429
0.040
 Why?
Clinical Decision-Making
1
2021
319
0.040
 Why?
Whole-Body Irradiation
1
2018
78
0.040
 Why?
Fetal Blood
1
2020
327
0.040
 Why?
HLA Antigens
1
2019
237
0.040
 Why?
Antineoplastic Agents, Immunological
1
2020
189
0.030
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
15
0.030
 Why?
Cell Count
1
2018
323
0.030
 Why?
Biological Transport
1
2018
417
0.030
 Why?
Child
2
2024
21999
0.030
 Why?
Disease Models, Animal
2
2020
4284
0.030
 Why?
Tumor Stem Cell Assay
1
2017
34
0.030
 Why?
Glutathione
1
2019
358
0.030
 Why?
Combined Modality Therapy
1
2020
1237
0.030
 Why?
Retinal Dehydrogenase
1
2017
30
0.030
 Why?
Diet, High-Fat
1
2018
247
0.030
 Why?
Oxides
1
2017
46
0.030
 Why?
Arsenicals
1
2017
30
0.030
 Why?
Glycolysis
1
2018
319
0.030
 Why?
Benzothiazoles
1
2016
33
0.030
 Why?
Adenosine Triphosphate
1
2019
487
0.030
 Why?
NADP
1
2016
50
0.030
 Why?
Heterografts
1
2017
138
0.030
 Why?
Hydrazines
1
2016
35
0.030
 Why?
Cyclophosphamide
1
2017
248
0.030
 Why?
Deoxyglucose
1
2016
53
0.030
 Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
10
0.030
 Why?
Tumor Microenvironment
1
2020
674
0.030
 Why?
Drug Combinations
1
2017
344
0.030
 Why?
Receptors, Interleukin-1
1
2017
216
0.030
 Why?
Reactive Oxygen Species
1
2019
622
0.030
 Why?
Sample Size
1
2016
127
0.030
 Why?
Kinetics
1
2019
1674
0.030
 Why?
Transcriptome
1
2022
972
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2017
283
0.030
 Why?
Sequence Analysis, RNA
1
2018
452
0.030
 Why?
Isoenzymes
1
2016
304
0.030
 Why?
Positron-Emission Tomography
1
2017
295
0.030
 Why?
Splenomegaly
1
2015
15
0.030
 Why?
Health Services Accessibility
1
2023
982
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2017
365
0.030
 Why?
Metabolome
1
2018
350
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2017
382
0.030
 Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
 Why?
Ketone Oxidoreductases
1
2014
7
0.030
 Why?
Lipid Metabolism
1
2018
512
0.030
 Why?
Hydroxyurea
1
2015
35
0.030
 Why?
Repressor Proteins
1
2018
427
0.030
 Why?
Comorbidity
2
2013
1624
0.030
 Why?
Diagnosis, Differential
1
2019
1484
0.030
 Why?
Fluorescent Antibody Technique
1
2015
388
0.030
 Why?
Interleukin-1beta
1
2017
372
0.030
 Why?
Membrane Potential, Mitochondrial
1
2014
71
0.030
 Why?
Imatinib Mesylate
1
2014
79
0.030
 Why?
Sirolimus
1
2016
275
0.030
 Why?
Immunologic Factors
1
2017
237
0.030
 Why?
Cell Differentiation
1
2022
1987
0.030
 Why?
Quality of Life
2
2016
2885
0.030
 Why?
Sequence Homology, Amino Acid
1
2015
387
0.030
 Why?
Superoxides
1
2014
202
0.030
 Why?
Dasatinib
1
2014
54
0.030
 Why?
Age of Onset
1
2015
519
0.030
 Why?
Structure-Activity Relationship
1
2015
574
0.030
 Why?
Thiazoles
1
2014
123
0.030
 Why?
Genetic Heterogeneity
1
2014
59
0.030
 Why?
Leukemia, Lymphoid
1
2013
27
0.030
 Why?
Up-Regulation
1
2016
844
0.030
 Why?
Research Design
1
2020
1128
0.030
 Why?
Trans-Activators
1
2016
398
0.030
 Why?
Drug Synergism
1
2014
383
0.030
 Why?
Cyclosporine
1
2014
268
0.030
 Why?
Pulmonary Diffusing Capacity
1
2013
75
0.030
 Why?
RNA Interference
1
2014
467
0.030
 Why?
Phosphorylation
1
2017
1759
0.020
 Why?
Mice, Inbred BALB C
1
2015
1269
0.020
 Why?
Polymorphism, Single Nucleotide
1
2020
2195
0.020
 Why?
Homeodomain Proteins
1
2016
506
0.020
 Why?
Cost-Benefit Analysis
1
2015
586
0.020
 Why?
Thrombosis
1
2015
368
0.020
 Why?
Leupeptins
1
2011
10
0.020
 Why?
HL-60 Cells
1
2011
34
0.020
 Why?
Respiratory Function Tests
1
2013
596
0.020
 Why?
Cysteine Proteinase Inhibitors
1
2011
49
0.020
 Why?
Proteasome Inhibitors
1
2011
46
0.020
 Why?
Mitoxantrone
1
2010
14
0.020
 Why?
Free Radical Scavengers
1
2011
88
0.020
 Why?
Genotype
1
2015
1923
0.020
 Why?
Molecular Sequence Data
1
2015
2904
0.020
 Why?
Etoposide
1
2010
157
0.020
 Why?
Acetylcysteine
1
2011
145
0.020
 Why?
Neoplasms, Experimental
1
2011
176
0.020
 Why?
Mutagenesis, Site-Directed
1
2011
376
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
155
0.020
 Why?
Prospective Studies
2
2016
7595
0.020
 Why?
Prevalence
1
2016
2715
0.020
 Why?
Treatment Failure
1
2010
354
0.020
 Why?
Models, Biological
1
2017
1773
0.020
 Why?
Insulin
1
2018
2406
0.020
 Why?
RNA-Binding Proteins
1
2011
424
0.020
 Why?
Nitroimidazoles
1
2004
9
0.010
 Why?
Cyclohexanes
1
2004
21
0.010
 Why?
Fluorescein
1
2004
25
0.010
 Why?
In Situ Nick-End Labeling
1
2004
124
0.010
 Why?
Radiation-Sensitizing Agents
1
2004
43
0.010
 Why?
Lectins
1
2004
49
0.010
 Why?
Microcirculation
1
2004
146
0.010
 Why?
Neoplasm Transplantation
1
2004
257
0.010
 Why?
In Situ Hybridization
1
2004
316
0.010
 Why?
Capillaries
1
2004
108
0.010
 Why?
Antibiotics, Antineoplastic
1
2004
130
0.010
 Why?
Angiography
1
2004
207
0.010
 Why?
Wilms Tumor
1
2004
86
0.010
 Why?
Neovascularization, Pathologic
1
2004
301
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2004
544
0.010
 Why?
Immunohistochemistry
1
2004
1734
0.010
 Why?
Hypoxia
1
2004
1111
0.010
 Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (59) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)